Loading...
A prospective longitudinal study of Pasireotide in Nelson's syndrome.
Daniel, E Debono, M Caunt, S Girio-Fragkoulakis, C Walters, S Akker, S Grossman, A Trainer, Peter J Newell-Price, J
Daniel, E
Debono, M
Caunt, S
Girio-Fragkoulakis, C
Walters, S
Akker, S
Grossman, A
Trainer, Peter J
Newell-Price, J
Citations
Altmetric:
Abstract
Nelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma ACTH and tumor volume in Nelson's syndrome.
Description
Date
2018-01-08
Publisher
Collections
Files
Keywords
Type
Article
Citation
A prospective longitudinal study of Pasireotide in Nelson's syndrome. 2018 Pituitary